Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
RBC Maint. REGN (Regeneron Pharmaceuticals, Inc.) at Sector Perform, PT $765 Mar 2026
RBC Capital has maintained its “Sector Perform” rating for Regeneron Pharmaceuticals (REGN) but increased its price target to $765, reflecting improved valuation assumptions without a full upgrade. This neutral stance suggests investors should hold current positions and look for further clinical or commercial catalysts. Meyka AI rates REGN with an “A” grade, factoring in market comparisons, sector performance, financial growth, and analyst consensus.